Our approach
Our services
Our people
Contact us
News and resources
Join us
Our approach
Thought
Freshness
Simplicity
Value
Teamwork
Reach
Advice
Reality
Case studies
Our services
What we do
Patents
Trade Marks and Domain Names
Designs and Copyright
IP Consulting
Contact us
Map (Google maps)
Congestion Charge and Car Parking
Public transport
Travel from London's airports
Travel links
Enquiry form
News and resources
News
Links
Downloads
Client Workbench
 

Welcome to Keltie

What's new

Keltie is a partnership of patent and trade mark attorneys based in the City of London.

We act directly before the UKIPO, EPO, OHIM and WIPO in all IP matters including patent, trade mark and design applications, oppositions and renewals on behalf of our clients.

Keltie acts globally in all fields of commerce and technology, across the full range of intellectual property law. Much more than just a filing agency, we also offer consultancy services to IP owners and managers.

Chambers and Partners ranks Keltie among Britain's top ranked patent and trade mark firms, saying "This youthful, energetic team takes a practical, no-nonsense approach to matters, impressing clients with its organised and diligent work ethic. With an innovative outlook and great commercial sense, Keltie handles filings, oppositions, renewals and enforcement issues from start to finish and also provides tactical advice."

The Queen's Award for Enterprise 

High praise for Keltie in 2011 Legal 500

Keltie has been ranked highly among patent and trade mark attorneys in the 2011 Legal 500.

In addition to praise for individuals within Keltie set out in their individual profiles, the firm as a whole attracted comments including:

 “Professional, commercially astute and knowledgeable”

“A breadth of sectoral expertise”

“A good, friendly team, and a no-nonsense approach”

No more patents for cells derived from human embryos in EU

The Court of Justice of the European Union (EU) has issued a key decision limiting the scope of protection available for inventions that claim human ES cells and their derivatives. These restrictions apply to the whole EU and go further than previous measures adopted by the European Patent Office in this area. More...

See all news articles

Visit our download page